Insmed Inc (INSM)

[markjohn62]

ALS therapy development foundation (ALSTDF)has entered a collaboration with the muscular dystrophy association and will be called ALS therapy institute.
Both of these organizations may benefit from INSM's work as als and mmd are posible indications for iplex.
The ALSTDF recently gave 24 million to CYTR for a 1% stake in the sales of arimoclomol if it makes it past the FDA. That kind of grant is like toxic financing without the toxic part, no dilution.

http://www.als.net/articles/articleDetail.asp?articleID=5169